| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 148, Issue 4 1182-1187, Copyright © 1992 by American Association of Immunologists
ARTICLES |
R Chatelain, K Varkila and RL Coffman
Department of Immunology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304.
The infection of mice with Leishmania major can cause either a fatal disseminated disease or a localized healing disease, depending on the genetic background of the mice. A strong correlation has been shown between disease outcome and the nature of the T cell response, with healer strains developing a Th1-like response and nonhealer strains a Th2-like response. The treatment of nonhealer BALB/c mice with a single dose of an anti-IL-4 antibody, given at the time of infection with L. major, allowed these mice to develop healing Th1-like responses, suggesting that IL-4 is required in BALB/c mice for the differentiation of Th cells into Th2 cells. Anti-IL-4 had to be present during the first 2 wk of infection to have this effect. Anti-IL-4 caused a marked shift from a Th2 to a Th1 pattern of cytokine expression within 4 days, in vivo, and injections of IL-4 had the opposite effect on the early response in healer C3H/HeN mice. These findings demonstrate that IL-4 can induce the development of Th2 response to L. major infection in vivo.
This article has been cited by other articles:
|
|
 |
|
  A. Salhi, V. Rodrigues Jr., F. Santoro, H. Dessein, A. Romano, L. R. Castellano, M. Sertorio, S. Rafati, C. Chevillard, A. Prata, et al. Immunological and Genetic Evidence for a Crucial Role of IL-10 in Cutaneous Lesions in Humans Infected with Leishmania braziliensis J. Immunol., May 1, 2008; 180(9): 6139 - 6148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. F. Tuon, V. S. Amato, H. A. Bacha, T. AlMusawi, M. I. Duarte, and V. Amato Neto Toll-Like Receptors and Leishmaniasis Infect. Immun., March 1, 2008; 76(3): 866 - 872. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Suzue, S. Kobayashi, T. Takeuchi, M. Suzuki, and S. Koyasu Critical role of dendritic cells in determining the Th1/Th2 balance upon Leishmania major infection Int. Immunol., March 1, 2008; 20(3): 337 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Field, S. Wagage, S. M. Conrad, and D. M. Mosser Reduced Pathology following Infection with Transgenic Leishmania major Expressing Murine CD40 Ligand Infect. Immun., June 1, 2007; 75(6): 3140 - 3149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xin, K. Ohmori, J. Nishida, Y. Zhu, and H. Huang The initial response of CD4+ IL-4-producing cells Int. Immunol., March 1, 2007; 19(3): 305 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Aratani, F. Kura, H. Watanabe, H. Akagawa, Y. Takano, A. Ishida-Okawara, K. Suzuki, N. Maeda, and H. Koyama Contribution of the myeloperoxidase-dependent oxidative system to host defence against Cryptococcus neoformans. J. Med. Microbiol., September 1, 2006; 55(Pt 9): 1291 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tanaka, M. Sato, T. Onitsuka, H. Kamata, and Y. Yokomizo Inflammatory Cytokine Gene Expression in Different Types of Granulomatous Lesions during Asymptomatic Stages of Bovine Paratuberculosis Vet. Pathol., September 1, 2005; 42(5): 579 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Suffia*, S. K. Reckling*, G. Salay*, and Y. Belkaid* A Role for CD103 in the Retention of CD4+CD25+ Treg and Control of Leishmania major Infection J. Immunol., May 1, 2005; 174(9): 5444 - 5455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu, Q. Liu, H. Hamed, R. M. Anthony, A. Foster, F. D. Finkelman, J. F. Urban Jr, and W. C. Gause IL-2 and Autocrine IL-4 Drive the In Vivo Development of Antigen-Specific Th2 T Cells Elicited by Nematode Parasites J. Immunol., February 15, 2005; 174(4): 2242 - 2249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yasumi, K. Katamura, I. Okafuji, T. Yoshioka, T.-a. Meguro, R. Nishikomori, T. Kusunoki, T. Heike, and T. Nakahata Limited Ability of Antigen-Specific Th1 Responses to Inhibit Th2 Cell Development In Vivo J. Immunol., February 1, 2005; 174(3): 1325 - 1331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. ROGERS and R. G. TITUS CHARACTERIZATION OF THE EARLY CELLULAR IMMUNE RESPONSE TO LEISHMANIA MAJOR USING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LEISHMANIA-NAIVE HUMANS Am J Trop Med Hyg, November 1, 2004; 71(5): 568 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. VANLOUBBEECK and D. E. JONES PROTECTION OF C3HEB/FEJ MICE AGAINST LEISHMANIA AMAZONENSIS CHALLENGE AFTER PREVIOUS LEISHMANIA MAJOR INFECTION Am J Trop Med Hyg, October 1, 2004; 71(4): 407 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. C. Babay, H. Louzir, C. Kebaier, S. Boubaker, K. Dellagi, and P.-A. Cazenave Inbred Strains Derived from Feral Mice Reveal New Pathogenic Mechanisms of Experimental Leishmaniasis Due to Leishmania major Infect. Immun., August 1, 2004; 72(8): 4603 - 4611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Campbell, H. Diao, J. Ji, and L. Soong DNA Immunization with the Gene Encoding P4 Nuclease of Leishmania amazonensis Protects Mice against Cutaneous Leishmaniasis Infect. Immun., November 1, 2003; 71(11): 6270 - 6278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Noben-Trauth, R. Lira, H. Nagase, W. E. Paul, and D. L. Sacks The Relative Contribution of IL-4 Receptor Signaling and IL-10 to Susceptibility to Leishmania major J. Immunol., May 15, 2003; 170(10): 5152 - 5158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. M. Padigel and J. P. Farrell CD40-CD40 Ligand Costimulation Is Not Required for Initiation and Maintenance of a Th1-Type Response to Leishmania major Infection Infect. Immun., March 1, 2003; 71(3): 1389 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. J. Pollock, K. S. McNeil, J. C. Mottram, R. E. Lyons, J. M. Brewer, P. Scott, G. H. Coombs, and J. Alexander The Leishmania mexicana Cysteine Protease, CPB2.8, Induces Potent Th2 Responses J. Immunol., February 15, 2003; 170(4): 1746 - 1753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kuroda and U. Yamashita Mechanisms of Enhanced Macrophage-Mediated Prostaglandin E2 Production and Its Suppressive Role in Th1 Activation in Th2-Dominant BALB/c Mice J. Immunol., January 15, 2003; 170(2): 757 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li, U. M. Padigel, P. Scott, and J. P. Farrell Combined Treatment with Interleukin-12 and Indomethacin Promotes Increased Resistance in BALB/c Mice with Established Leishmania major Infections Infect. Immun., October 1, 2002; 70(10): 5715 - 5720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aseffa, A. Gumy, P. Launois, H. R. MacDonald, J. A. Louis, and F. Tacchini-Cottier The Early IL-4 Response to Leishmania major and the Resulting Th2 Cell Maturation Steering Progressive Disease in BALB/c Mice Are Subject to the Control of Regulatory CD4+CD25+ T Cells J. Immunol., September 15, 2002; 169(6): 3232 - 3241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kuroda, T. Kito, and U. Yamashita Reduced Expression of STAT4 and IFN-{gamma} in Macrophages from BALB/c Mice J. Immunol., June 1, 2002; 168(11): 5477 - 5482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Launois, A. Gumy, H. Himmelrich, R. M. Locksley, M. Rocken, and J. A. Louis Rapid IL-4 Production by Leishmania Homolog of Mammalian RACK1-Reactive CD4+ T Cells in Resistant Mice Treated Once with Anti-IL-12 or -IFN-{gamma} Antibodies at the Onset of Infection with Leishmania major Instructs Th2 Cell Development, Resulting in Nonhealing Lesions J. Immunol., May 1, 2002; 168(9): 4628 - 4635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Compton and J. P. Farrell CD28 Costimulation and Parasite Dose Combine to Influence the Susceptibility of BALB/c Mice to Infection with Leishmania major J. Immunol., February 1, 2002; 168(3): 1302 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Jones, L. M. Hodge, K. Fujihashi, H. Kiyono, J. R. McGhee, and J. W. Simecka The Pulmonary Environment Promotes Th2 Cell Responses After Nasal-Pulmonary Immunization with Antigen Alone, but Th1 Responses Are Induced During Instances of Intense Immune Stimulation J. Immunol., October 15, 2001; 167(8): 4518 - 4526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Zhang, Y. Maekawa, T. Sakai, Y. Nakano, K. Ishii, H. Hisaeda, T. Dainichi, T. Asao, N. Katunuma, and K. Himeno Treatment with cathepsin L inhibitor potentiates Th2-type immune response in Leishmania major-infected BALB/c mice Int. Immunol., August 1, 2001; 13(8): 975 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Hurst, B. W. P. Seymour, T. Muchamuel, V. P. Kurup, and R. L. Coffman Modulation of Inhaled Antigen-Induced IgE Tolerance by Ongoing Th2 Responses in the Lung J. Immunol., April 15, 2001; 166(8): 4922 - 4930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Nagabhushanam and C. Cheers Non-Major Histocompatibility Complex Control of Antibody Isotype and Th1 versus Th2 Cytokines during Experimental Infection of Mice with Mycobacterium avium Infect. Immun., March 1, 2001; 69(3): 1708 - 1713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. I. Brodskyn, G. K. DeKrey, and R. G. Titus Influence of Costimulatory Molecules on Immune Response to Leishmania major by Human Cells In Vitro Infect. Immun., February 1, 2001; 69(2): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. B. Kremer, M. P. Gould, K. D. Cooper, and F. P. Heinzel Pretreatment with Recombinant Flt3 Ligand Partially Protects against Progressive Cutaneous Leishmaniasis in Susceptible BALB/c Mice Infect. Immun., February 1, 2001; 69(2): 673 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Torrentera, N. Glaichenhaus, J. D. Laman, and Y. Carlier T-Cell Responses to Immunodominant LACK Antigen Do Not Play a Critical Role in Determining Susceptibility of BALB/c Mice to Leishmania mexicana Infect. Immun., January 1, 2001; 69(1): 617 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. C. Lonardoni, M. Russo, and S. Jancar Essential Role of Platelet-Activating Factor in Control of Leishmania (Leishmania) amazonensis Infection Infect. Immun., November 1, 2000; 68(11): 6355 - 6361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Hural, M. Kwan, G. Henkel, M. B. Hock, and M. A. Brown An Intron Transcriptional Enhancer Element Regulates IL-4 Gene Locus Accessibility in Mast Cells J. Immunol., September 15, 2000; 165(6): 3239 - 3249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ohta, M. Sekimoto, M. Sato, T. Koda, S.-i. Nishimura, Y. Iwakura, K. Sekikawa, and T. Nishimura Indispensable Role for TNF-{alpha} and IFN-{gamma} at the Effector Phase of Liver Injury Mediated by Th1 Cells Specific to Hepatitis B Virus Surface Antigen J. Immunol., July 15, 2000; 165(2): 956 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Belkaid, S. Mendez, R. Lira, N. Kadambi, G. Milon, and D. Sacks A Natural Model of Leishmania major Infection Reveals a Prolonged ""Silent"" Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity J. Immunol., July 15, 2000; 165(2): 969 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Satoh, J. P. Weintraub, H. Yoshida, V. M. Shaheen, H. B. Richards, M. Shaw, and W. H. Reeves Fas and Fas Ligand Mutations Inhibit Autoantibody Production in Pristane-Induced Lupus J. Immunol., July 15, 2000; 165(2): 1036 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Himmelrich, P. Launois, I. Maillard, T. Biedermann, F. Tacchini-Cottier, R. M. Locksley, M. Rocken, and J. A. Louis In BALB/c Mice, IL-4 Production During the Initial Phase of Infection with Leishmania major Is Necessary and Sufficient to Instruct Th2 Cell Development Resulting in Progressive Disease J. Immunol., May 1, 2000; 164(9): 4819 - 4825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mohrs, C. Holscher, and F. Brombacher Interleukin-4 Receptor Alpha-Deficient BALB/c Mice Show an Unimpaired T Helper 2 Polarization in Response to Leishmania major Infection Infect. Immun., April 1, 2000; 68(4): 1773 - 1780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Abrahamsohn, A. P. G. da Silva, and R. L. Coffman Effects of Interleukin-4 Deprivation and Treatment on Resistance to Trypanosoma cruzi Infect. Immun., April 1, 2000; 68(4): 1975 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Morris, W. C. Gause, and F. D. Finkelman IL-4 Suppression of In Vivo T Cell Activation and Antibody Production J. Immunol., February 15, 2000; 164(4): 1734 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Akiba, Y. Miyahira, M. Atsuta, K. Takeda, C. Nohara, T. Futagawa, H. Matsuda, T. Aoki, H. Yagita, and K. Okumura Critical Contribution of OX40 Ligand to T Helper Cell Type 2 Differentiation in Experimental Leishmaniasis J. Exp. Med., January 17, 2000; 191(2): 375 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hayashi, K. Matsui, H. Tsutsui, Y. Osada, R. T. Mohamed, H. Nakano, S.-i. Kashiwamura, Y. Hyodo, K. Takeda, S. Akira, et al. Kupffer Cells from Schistosoma mansoni-Infected Mice Participate in the Prompt Type 2 Differentiation of Hepatic T Cells in Response to Worm Antigens J. Immunol., December 15, 1999; 163(12): 6702 - 6711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Dent, T. M. Doherty, W. E. Paul, A. Sher, and L. M. Staudt BCL-6-Deficient Mice Reveal an IL-4-Independent, STAT6-Dependent Pathway That Controls Susceptibility to Infection by Leishmania major J. Immunol., August 15, 1999; 163(4): 2098 - 2103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mata and Y. Paterson Th1 T Cell Responses to HIV-1 Gag Protein Delivered by a Listeria monocytogenes Vaccine Are Similar to Those Induced by Endogenous Listerial Antigens J. Immunol., August 1, 1999; 163(3): 1449 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Heinzel and R. M. Rerko Cure of Progressive Murine Leishmaniasis: Interleukin 4 Dominance Is Abolished by Transient CD4+ T Cell Depletion and T Helper Cell Type 1-selective Cytokine Therapy J. Exp. Med., June 21, 1999; 189(12): 1895 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mohrs, B. Ledermann, G. Kohler, A. Dorfmuller, A. Gessner, and F. Brombacher Differences Between IL-4- and IL-4 Receptor {alpha}-Deficient Mice in Chronic Leishmaniasis Reveal a Protective Role for IL-13 Receptor Signaling J. Immunol., June 15, 1999; 162(12): 7302 - 7308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishimura and A. Ohta A Critical Role for Antigen-Specific Th1 Cells in Acute Liver Injury in Mice J. Immunol., June 1, 1999; 162(11): 6503 - 6509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Elloso and P. Scott Expression and Contribution of B7-1 (CD80) and B7-2 (CD86) in the Early Immune Response to Leishmania major Infection J. Immunol., June 1, 1999; 162(11): 6708 - 6715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Noben-Trauth, W. E. Paul, and D. L. Sacks IL-4- and IL-4 Receptor-Deficient BALB/c Mice Reveal Differences in Susceptibility to Leishmania major Parasite Substrains J. Immunol., May 15, 1999; 162(10): 6132 - 6140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Guler, J. D. Gorham, W. F. Dietrich, T. L. Murphy, R. G. Steen, C. A. Parvin, D. Fenoglio, A. Grupe, G. Peltz, and K. M. Murphy Tpm1, a Locus Controlling IL-12 Responsiveness, Acts by a Cell-Autonomous Mechanism J. Immunol., February 1, 1999; 162(3): 1339 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Gabaglia, B. Pedersen, M. Hitt, N. Burdin, E. E. Sercarz, F. L. Graham, J. Gauldie, and T. A. Braciak A Single Intramuscular Injection with an Adenovirus- Expressing IL-12 Protects BALB/c Mice Against Leishmania major Infection, While Treatment with an IL-4-Expressing Vector Increases Disease Susceptibility in B10.D2 Mice J. Immunol., January 15, 1999; 162(2): 753 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Oxenius, U. Karrer, R. M. Zinkernagel, and H. Hengartner IL-12 Is Not Required for Induction of Type 1 Cytokine Responses in Viral Infections J. Immunol., January 15, 1999; 162(2): 965 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li, C. A. Hunter, and J. P. Farrell Anti-TGF-{beta} Treatment Promotes Rapid Healing of Leishmania major Infection in Mice by Enhancing In Vivo Nitric Oxide Production J. Immunol., January 15, 1999; 162(2): 974 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Alexander, A. Satoskar, and D. Russell Leishmania species: models of intracellular parasitism J. Cell Sci., January 9, 1999; 112(18): 2993 - 3002. [Abstract] [PDF]
|
|
|
|
|
|
K. Hung, R. Hayashi, A. Lafond-Walker, C. Lowenstein, D. Pardoll, and H. Levitsky The Central Role of CD4+ T Cells in the Antitumor Immune Response J. Exp. Med., December 21, 1998; 188(12): 2357 - 2368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Stamm, A. Raisanen-Sokolowski, M. Okano, M. E. Russell, J. R. David, and A. R. Satoskar Mice with STAT6-Targeted Gene Disruption Develop a Th1 Response and Control Cutaneous Leishmaniasis J. Immunol., December 1, 1998; 161(11): 6180 - 6188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Mbow, J. A. Bleyenberg, L. R. Hall, and R. G. Titus Phlebotomus papatasi Sand Fly Salivary Gland Lysate Down-Regulates a Th1, but Up-Regulates a Th2, Response in Mice Infected with Leishmania major J. Immunol., November 15, 1998; 161(10): 5571 - 5577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Assenmacher, M. Lohning, A. Scheffold, A. Richter, S. Miltenyi, J. Schmitz, and A. Radbruch Commitment of Individual Th1-Like Lymphocytes to Expression of IFN-{gamma} Versus IL-4 and IL-10: Selective Induction of IL-10 by Sequential Stimulation of Naive Th Cells with IL-12 and IL-4 J. Immunol., September 15, 1998; 161(6): 2825 - 2832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Maekawa, K. Himeno, H. Ishikawa, H. Hisaeda, T. Sakai, T. Dainichi, T. Asao, R. A Good, and N. Katunuma Switch of CD4+ T Cell Differentiation from Th2 to Th1 by Treatment with Cathepsin B Inhibitor in Experimental Leishmaniasis J. Immunol., September 1, 1998; 161(5): 2120 - 2127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. M. ten Hagen, W. van Vianen, H. F. J. Savelkoul, H. Heremans, W. A. Buurman, and I. A. J. M. Bakker-Woudenberg Involvement of T Cells in Enhanced Resistance to Klebsiella pneumoniae Septicemia in Mice Treated with Liposome-Encapsulated Muramyl Tripeptide Phosphatidylethanolamine or Gamma Interferon Infect. Immun., May 1, 1998; 66(5): 1962 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Moriggl, C. Kristofic, B. Kinzel, S. Volarevic, B. Groner, and V. Brinkmann1 Activation of STAT Proteins and Cytokine Genes in Human Th1 and Th2 Cells Generated in the Absence of IL-12 and IL-4 J. Immunol., April 1, 1998; 160(7): 3385 - 3392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Ning, D. Brown, J. Parodo, M. Cattral, R. Gorczynski, E. Cole, L. Fung, J. W. Ding, M. F. Liu, O. Rotstein, et al. Ribavirin Inhibits Viral-Induced Macrophage Production of TNF, IL-1, the Procoagulant fgl2 Prothrombinase and Preserves Th1 Cytokine Production But Inhibits Th2 Cytokine Response J. Immunol., April 1, 1998; 160(7): 3487 - 3493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
|
